1Kitano S, Iso Y, Moriyama M, et al. Laparoscopy- assisted Billroth I gastrectomy[J]. Surg Laparosc Endosc, 1994, 4 (2) : 146.
2Jacobs M, Verdeja J C, Goldstein H S. Minimally invasive colon resection ( laparoscopic colectomy) [ J ]. Surg Laparosc Endosc, 1991, 1(3): 144.
3Corder. 20 years of development and prospect of laparoscopic gastrointestinal tumors [ J ]. Journal of theory and practice of surgery, 2009, 14(6): 583.
4Staudacher C, Vigrmli A, Saverio D P, et al. Laparoscopicvs. open total mesorectal excision in unselecled patientswith rectal cancer: impact on early outcome [J ]. Disc Colon Rectum, 2007, 50(9): 1324.
5COLon Cancer Laparoscopic or Open Resection Study Group, Buunen M, VeLdkamp R, et al. Survival after laparoscopic- surgery versus open surgery for colon cancer: Long- termout- come of a randomized clinical trial[J]. Lancet Oncol, 2009, 10(1) : 44.
6Jayne D G, GuiLLou P J, Thorpe H, et al. Randomized tri- aLof iaparoscopic- assisted resection of colorectal carcinoma: 3 -year resuLts of the UK MRC CLASICC Trial Group [ J ]. JCLin Oncol, 2007, 25(21): 3061.
5Ye X F, Wang J, Shi W T, et al. Relationship between aspi tin use after diagnosis of colorectal cancer and patient survival a meta - analysis of observational studies [ J]. Br J Cancer 2014, 111(11): 2172-2179.
6Zhang C, Wang J, Gu H, et al. Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colo- rectal cancer: Meta-analysis of randomized controlled trials [J]. OncolLett, 2012, 3(4): 831 -838.
7Esteban F, Cerdan F J, Garcia-Alonso M, et al. A multicen- tre comparison of a fast track or conventional postoperative pro- tocol following laparoscopic or open elective surgery for colorec- tal cancer surgery[J].Colorectal Dis, 2014, 16: 134- 140.
8Sakaguchi S, Sakaguchi N, Asano M, et al. Pillars article: immunologic self-tolerance maintained by activated T cells ex- pressing IL-2 receptor a-chains( CDz5 ). Breakdown of a single mechanism of self-tolerance causes various autoimmune disea- ses. J. Immunol. 1995[J].J Immunol, 2011, 186(7): 3808 - 3821.
9Qiu J,Yu Y,Fu Y,et al.Preoperative plasma fibrinogen,platelet count and prognosis in epithelial ovarian cancer[J].J Obstet Gynaecol Res,2012,38(4):651-657.
10Mego M,Karaba M,Minarik G,et al.Relationship between circulating tumor cells,blood coagulation,and urokinaseplasminogen-activator system in early breast cancer patients[J].Breast J,2015,21(2):155-160.